Vision Loss Risk Under Scrutiny: Ozempic,Wegovy Face New Scrutiny Over Potential Eye Condition Link The Popular Weight Loss Drugs Wegovy And Ozempic,Manufactured By Novo Nordisk,Are Under Increased Scrutiny Following Reports Linking Them To A Rare But Serious Eye Condition. European Regulators Are Investigating The Potential for Vision Loss Associated With Thes Medications, Adding A New … Read more
Hhs Secretary Kennedy Jr. Fires Vaccine Advisors, Sparking Public Health Concerns Washington D.C. – In a move that has sent ripples through the public health community, Health And Human Services (Hhs) Secretary Robert F. Kennedy Jr.has dismissed all 17 members of the Advisory Committee on Immunization Practices (Acip), a crucial panel advising the Centers For … Read more
Fda Approves Merck’s Enflonsia Rsv Shot For Infants, Rivaling Sanofi And Astrazeneca’s Beyfortus Fda Approves Merck’s Enflonsia Rsv Shot For Infants, Rivaling Sanofi And Astrazeneca’s Beyfortus Washington D.C. – In A Landmark Decision, The Food And Drug Governance (fda) Has Approved Merck’s Enflonsia, A Shot Designed To Protect Infants From Respiratory Syncytial Virus (Rsv) During … Read more
Eli Lilly Reports Fourth-Quarter Earnings: A Mixed Bag Table of Contents 1. Eli Lilly Reports Fourth-Quarter Earnings: A Mixed Bag 2. Earnings and Revenue: Surpassing Expectations on Profit, Falling Short on Revenue 3. Looking Ahead: 2025 Guidance Remains on Track 4. Key Product Performance: Mounjaro’s Growth Spiked, But Pricing Pressures Eased Growth 5. Retatrutide: Countdown … Read more